Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 8,643.09 187.35 -41.32 -1,407.88 -30.54 0.00 4.1841 -0.51 -0.1365 -22.3175 -0.09 -0.09 7.7195 - -
Maximum - - - - - - 133,371.00 2,687.00 1,099.00 12,431.00 1,058.00 0.01 701.8537 6.52 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -16.7400 -1,444.7800 -1.56 -12.64 0.0007 - -
Sarepta Therapeutics, Inc. SRPT 121.61 1.19 0.99% 1,432 vs. 876 11,597.00 413.00 36.00 -284.00 -4,410.00 0.3800 83.5325 0.0000 0.8777 0.0874 0.0376 0.0112 2.9737 95.00
Regeneron Pharmaceuticals, Inc. REGN 828.42 3.94 0.48% 556 vs. 639 89,529.00 3,145.00 722.00 1,350.00 27,982.00 6.7000 36.1813 0.0000 0.8258 0.2296 0.0267 0.0210 4.3960 108.00
Beam Therapeutics Inc. BEAM 27.06 0.96 3.68% 1,110 vs. 865 2,230.00 7.00 -98.00 -102.00 -1,288.00 -1.2100 -6.7607 0.0000 0.2671 -13.3157 -0.1080 -0.0726 5.8464 82.00
Krystal Biotech, Inc. KRYS 199.61 14.16 7.64% 400 vs. 209 5,734.00 45.00 0.00 14.00 -268.00 0.0300 1336.3467 0.0000 0.9465 0.0206 0.0012 0.0011 12.2870 28.00
Intellia Therapeutics, Inc. NTLA 16.73 0.73 4.56% 2,370 vs. 1,884 1,699.00 28.00 -107.00 -123.00 -1,765.00 -1.1200 -6.0491 0.0000 0.9132 -3.7130 -0.1037 -0.0853 8.4537 101.00
CRISPR Therapeutics AG CRSP 51.62 -0.26 -0.50% 1,291 vs. 1,115 4,405.00 0.00 -116.00 109.00 -1,116.00 -1.4300 -11.9580 0.0000 -101.7758 -231.3313 -0.0559 -0.0478 17.7168 85.00
Novo Nordisk A/S NVO 107.20 -0.43 -0.40% 5,217 vs. 4,207 475,026.00 65,349.00 25,407.00 5,305.00 99,050.00 5.7000 38.8598 0.0072 0.8483 0.3888 0.2569 0.0850 0.4372 4,431.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for CRSP and its peers to uncover potential buy and sell opportunities.